- Home
- TTI vs NRIX Comparison
TTI vs NRIX Comparison
Compare TTI & NRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TTI | NRIX |
|---|---|---|
| Founded | 1981 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.6B |
| IPO Year | 1996 | 2020 |
Fundamental Metrics
Financial Performance| Metric | TTI | NRIX |
|---|---|---|
| Price | $8.39 | $16.25 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 12 |
| Target Price | $10.40 | ★ $30.50 |
| AVG Volume (30 Days) | ★ 1.5M | 1.2M |
| Earning Date | 04-29-2026 | 04-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | N/A | ★ $76,987,000.00 |
| Revenue This Year | $4.70 | N/A |
| Revenue Next Year | $11.35 | $40.12 |
| P/E Ratio | $420.25 | ★ N/A |
| Revenue Growth | N/A | ★ 99.31 |
| 52 Week Low | $2.31 | $8.20 |
| 52 Week High | $12.54 | $22.50 |
Technical Indicators
Market Signals| Indicator | TTI | NRIX |
|---|---|---|
| Relative Strength Index (RSI) | 45.73 | 56.34 |
| Support Level | $6.88 | $14.61 |
| Resistance Level | $8.90 | $16.47 |
| Average True Range (ATR) | 0.44 | 1.01 |
| MACD | 0.08 | 0.15 |
| Stochastic Oscillator | 45.59 | 67.63 |
Price Performance
Historical ComparisonAbout TTI Tetra Technologies Inc.
Tetra Technologies Inc is a diversified oil and gas services company, focused on completion fluids and associated products and services, water management, frac flowback, production well testing, offshore rig cooling, and compression services. It has two reporting segments, namely Completion Fluids & Products and Water & Flowback Services. The Completion Fluids & Products Division manufactures and markets clear brine fluids, additives, and associated products and services. The Water & Flowback Services Segment provides onshore oil and gas operators with comprehensive water management services. The majority of revenue is from the Completion Fluids & Products segment.
About NRIX Nurix Therapeutics Inc.
Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.